<VariationArchive VariationID="827809" VariationName="NM_001379403.1(WDR26):c.454del (p.Asp152fs)" VariationType="Deletion" Accession="VCV000827809" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2020-03-26" MostRecentSubmission="2020-03-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="815976" VariationID="827809">
      <GeneList>
        <Gene Symbol="WDR26" FullName="WD repeat domain 26" GeneID="80232" HGNC_ID="HGNC:21208" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.11-42.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="224385146" stop="224434797" display_start="224385146" display_stop="224434797" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="224572844" stop="224622000" display_start="224572844" display_stop="224622000" Strand="-" />
          </Location>
          <OMIM>617424</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WDR26">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WDR26">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001379403.1(WDR26):c.454del (p.Asp152fs)</Name>
      <CanonicalSPDI>NC_000001.11:224433951:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q42.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="224433952" stop="224433952" display_start="224433952" display_stop="224433952" variantLength="1" positionVCF="224433951" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="224621654" stop="224621654" display_start="224621654" display_stop="224621654" variantLength="1" positionVCF="224621653" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>D52fs</ProteinChange>
      <ProteinChange>D152fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.224621658del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.224621658del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.224433956del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.224433956del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_047198.1" sequenceAccession="NG_047198" sequenceVersion="1" change="g.5348del">
            <Expression>NG_047198.1:g.5348del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001115113.3" sequenceAccession="NM_001115113" sequenceVersion="3" change="c.154del">
            <Expression>NM_001115113.3:c.154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108585.2" sequenceAccession="NP_001108585" sequenceVersion="2" change="p.Asp52fs">
            <Expression>NP_001108585.2:p.Asp52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379403.1" sequenceAccession="NM_001379403" sequenceVersion="1" change="c.454del" MANESelect="true">
            <Expression>NM_001379403.1:c.454del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366332.1" sequenceAccession="NP_001366332" sequenceVersion="1" change="p.Asp152fs">
            <Expression>NP_001366332.1:p.Asp152fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025160.7" sequenceAccession="NM_025160" sequenceVersion="7" change="c.154del">
            <Expression>NM_025160.7:c.154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079436.4" sequenceAccession="NP_079436" sequenceVersion="4" change="p.Asp52fs">
            <Expression>NP_079436.4:p.Asp52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025160.6" sequenceAccession="NM_025160" sequenceVersion="6" change="c.154delG">
            <Expression>NM_025160.6:c.154delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1572227260" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001379403.1(WDR26):c.454del (p.Asp152fs) AND Skraban-Deardorff syndrome" Accession="RCV001027701" Version="3">
        <ClassifiedConditionList TraitSetID="37041">
          <ClassifiedCondition DB="MedGen" ID="C4539927">Skraban-Deardorff syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-08-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-08-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-03-26" MostRecentSubmission="2020-03-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="37041" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="37989" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DISABILITY WITH SEIZURES, ABNORMAL GAIT, AND DISTINCTIVE FACIAL FEATURES</ElementValue>
                <XRef Type="MIM" ID="617616" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Skraban-Deardorff syndrome</ElementValue>
                <XRef ID="MONDO:0054636" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SKDEAS</ElementValue>
                <XRef Type="MIM" ID="617616" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">WDR26-related intellectual disability (ID) is characterized by developmental delay / intellectual disability, characteristic facial features, hypotonia, epilepsy, and infant feeding difficulties. To date 15 individuals, ages 24 months to 34 years, have been reported. Developmental delay is present in all individuals and ranges from mild to severe. All individuals have delayed speech. Although some begin to develop speech in the second year, others have remained nonverbal. Seizures, present in all affected individuals reported to date, can be febrile or non-febrile (tonic-clonic, absence, rolandic seizures); most seizures are self limited or respond well to standard treatment. Affected individuals are generally described as happy and socially engaging; several have stereotypies / autistic features (repetitive or rocking behavior, abnormal hand movements or posturing, and at times self-stimulation).</Attribute>
                <XRef ID="NBK540448" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17953" />
                <XRef ID="17953" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">WDR26-Related Intellectual Disability</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31021590</ID>
                <ID Source="BookShelf">NBK540448</ID>
              </Citation>
              <XRef ID="513456" DB="Orphanet" />
              <XRef ID="C4539927" DB="MedGen" />
              <XRef ID="MONDO:0054636" DB="MONDO" />
              <XRef Type="MIM" ID="617616" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2348290" SubmissionDate="2019-10-17" DateLastUpdated="2020-03-26" DateCreated="2020-03-26">
        <ClinVarSubmissionID localKey="PED3813.1|OMIM:617616" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001190279" DateUpdated="2020-03-26" DateCreated="2020-03-26" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Université de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741869</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WDR26" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025160.6:c.154delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617616" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6436559</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2348290" TraitType="Disease" MappingType="XRef" MappingValue="617616" MappingRef="OMIM">
        <MedGen CUI="C4539927" Name="Skraban-Deardorff syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

